We explore models for the natural history of breast cancer, where the main events of interest are the start of asymptomatic detectability of the disease (through screening) and the time of symptomatic detection (through symptoms). We develop several parametric specifications based on a cure rate structure, and present the results of the analysis of data collected as part of a motivating study from Milan. Participants in the study were part of a regional breast cancer screening program, and their ten-year trajectories were obtained from administrative data available from the Italian national health care system. We first present a tractable model for which we develop the likelihood contributions of the observed trajectories and perform maximum likelihood inference on the latent process. Likelihood based inference is not feasible for more flexible models, and we implement approximate Bayesian computation (ABC) for inference. Issues that arise from the use of ABC for model choice and parameter estimation are discussed, including the problem of choosing appropriate summary statistics. The estimated parameters of the underlying disease process allow for the study of the effect of different examination schedules (age range and frequency of screening examinations) on a population of asymptomatic subjects.

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.9756DOI Listing

Publication Analysis

Top Keywords

breast cancer
12
approximate bayesian
8
bayesian computation
8
natural history
8
history breast
8
computation natural
4
cancer application
4
application data
4
data milan
4
milan cohort
4

Similar Publications

Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population.

Breast Cancer Res

January 2025

Servicio de Oncología, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, 66451, Monterrey, Nuevo León, México.

Background: Hereditary predisposition to breast and ovarian cancer syndrome (HBOC) is a pathological condition with increased cancer risk, including breast (BC), ovarian cancer (OC), and others. HBOC pathogenesis is caused mainly by germline pathogenic variants (GPV) in BRCA1 and BRCA2 genes. However, other relevant genes are related to this syndrome diagnosis, prognosis, and treatment, including TP53, PALB2, CHEK2, ATM, etc.

View Article and Find Full Text PDF

Genome-wide association studies are enriched for interacting genes.

BioData Min

January 2025

The Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90069, USA.

Background: With recent advances in single cell technology, high-throughput methods provide unique insight into disease mechanisms and more importantly, cell type origin. Here, we used multi-omics data to understand how genetic variants from genome-wide association studies influence development of disease. We show in principle how to use genetic algorithms with normal, matching pairs of single-nucleus RNA- and ATAC-seq, genome annotations, and protein-protein interaction data to describe the genes and cell types collectively and their contribution to increased risk.

View Article and Find Full Text PDF

Purpose: Breast cancer, as a stressful event, profoundly impacts the entire family, especially patients and their spouses. This study used a dyadic analysis approach to explore the dyadic effects of illness perception on the fear of cancer recurrence (FCR) and whether maladaptive cognitive-emotional regulation strategies acted as a mediator in breast cancer patient-spouse dyads.

Methods: This was a cross-sectional study, and 202 dyads of breast cancer patients and their spouses were enrolled.

View Article and Find Full Text PDF

Purpose: Women with breast cancer face a high degree of uncertainty. Trust between health providers and patients has been shown to improve patient quality of life and may enhance clinical outcomes. This study aimed to explore the meaning of trust along the treatment pathway.

View Article and Find Full Text PDF

Incidence of seroma and postoperative complications after breast surgery before and during the Covid-19 pandemic: results from a retrospective multicenter analysis.

BMC Cancer

January 2025

Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany.

Background: In recent years, there has been a growing number of case reports documenting delayed seroma in patients with a history of breast surgery and reconstruction. The occurrence of these seromas has been associated with prior SARS-CoV-2 infection or SARS-CoV-2 vaccination. So far, there are few systematic analyses on postoperative complications in breast surgery since the emergence of the SARS-CoV-2 pandemic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!